272 related articles for article (PubMed ID: 10544046)
1. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
Kemball-Cook G; Johnson DJ; Tuddenham EG; Harlos K
J Struct Biol; 1999 Oct; 127(3):213-23. PubMed ID: 10544046
[TBL] [Abstract][Full Text] [Related]
2. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of the N-terminal EGF-like domain from human factor VII.
Muranyi A; Finn BE; Gippert GP; Forsén S; Stenflo J; Drakenberg T
Biochemistry; 1998 Jul; 37(30):10605-15. PubMed ID: 9692950
[TBL] [Abstract][Full Text] [Related]
4. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
Jin J; Perera L; Stafford D; Pedersen L
J Mol Biol; 2001 Apr; 307(5):1503-17. PubMed ID: 11292356
[TBL] [Abstract][Full Text] [Related]
5. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
Zhang E; St Charles R; Tulinsky A
J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
[TBL] [Abstract][Full Text] [Related]
6. Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy.
Freskgård PO; Olsen OH; Persson E
Protein Sci; 1996 Aug; 5(8):1531-40. PubMed ID: 8844844
[TBL] [Abstract][Full Text] [Related]
7. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
[TBL] [Abstract][Full Text] [Related]
8. The solution structure of human coagulation factor VIIa in its complex with tissue factor is similar to free factor VIIa: a study of a heterodimeric receptor-ligand complex by X-ray and neutron scattering and computational modeling.
Ashton AW; Boehm MK; Johnson DJ; Kemball-Cook G; Perkins SJ
Biochemistry; 1998 Jun; 37(22):8208-17. PubMed ID: 9609717
[TBL] [Abstract][Full Text] [Related]
9. Sequential coagulation factor VIIa domain binding to tissue factor.
Osterlund M; Persson E; Carlsson U; Freskgård PO; Svensson M
Biochem Biophys Res Commun; 2005 Dec; 337(4):1276-82. PubMed ID: 16236263
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
Carlsson K; Persson E; Carlsson U; Svensson M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1111-6. PubMed ID: 16970919
[TBL] [Abstract][Full Text] [Related]
11. Crystallization and preliminary X-ray analysis of active site-inhibited human coagulation factor VIIa (des-Gla).
Johnson DJ; Nugent PG; Tuddenham EG; Harlos K; Kemball-Cook G
J Struct Biol; 1999 Mar; 125(1):90-3. PubMed ID: 10196120
[TBL] [Abstract][Full Text] [Related]
12. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.
Kao YH; Lee GF; Wang Y; Starovasnik MA; Kelley RF; Spellman MW; Lerner L
Biochemistry; 1999 Jun; 38(22):7097-110. PubMed ID: 10353820
[TBL] [Abstract][Full Text] [Related]
13. Predicted solution structure of zymogen human coagulation FVII.
Perera L; Darden TA; Pedersen LG
J Comput Chem; 2002 Jan; 23(1):35-47. PubMed ID: 11913388
[TBL] [Abstract][Full Text] [Related]
14. Prevention of beta strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIa.
Olsen OH; Nielsen PF; Persson E
Biochemistry; 2004 Nov; 43(44):14096-103. PubMed ID: 15518559
[TBL] [Abstract][Full Text] [Related]
15. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor.
Banner DW; D'Arcy A; Chène C; Winkler FK; Guha A; Konigsberg WH; Nemerson Y; Kirchhofer D
Nature; 1996 Mar; 380(6569):41-6. PubMed ID: 8598903
[TBL] [Abstract][Full Text] [Related]
16. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
Persson E; Olsen OH
FEBS J; 2009 Jun; 276(11):3099-109. PubMed ID: 19490111
[TBL] [Abstract][Full Text] [Related]
17. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
Ruf W; Shobe J; Rao SM; Dickinson CD; Olson A; Edgington TS
Biochemistry; 1999 Feb; 38(7):1957-66. PubMed ID: 10026279
[TBL] [Abstract][Full Text] [Related]
18. Model of a ternary complex between activated factor VII, tissue factor and factor IX.
Chen SW; Pellequer JL; Schved JF; Giansily-Blaizot M
Thromb Haemost; 2002 Jul; 88(1):74-82. PubMed ID: 12152682
[TBL] [Abstract][Full Text] [Related]
19. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
20. Transition state analysis of the complex between coagulation factor VIIa and tissue factor: suggesting a sequential domain-binding pathway.
Osterlund M; Persson E; Svensson M; Carlsson U; Freskgård PO
Biochem Biophys Res Commun; 2005 Feb; 327(3):789-93. PubMed ID: 15649415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
